Recent Updates
Recently added Catalysts
GEHC Positive Sentiment

Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow

Friday, October 16, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: GE HealthCare announced a study published in Anesthesia & Analgesia Practice, which evaluated its End-tidal Control software. Conducted at the University of Michigan, the research analyzed 12,818 adult general anesthesia cases. The findings suggest that the software may help reduce fresh gas flow in anesthesia practices.

Market Sentiment Analysis

POSITIVE FACTORS

  • Research shows potential benefits of GE HealthCare's software.
  • Study involved a large sample size of 12,818 cases.
  • Published in a reputable journal, Anesthesia & Analgesia Practice.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
2.5%
average across 3 past catalysts
Lead asset
PET MPI
Phase 3 · Coronary Artery Disease (CAD)

Full Press Release Details

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the publication of research conducted at the University of Michiganiv evaluating the use of End-tidal Control software across a large multisite academic health system in Anesthesia & Analgesia Practice. The retrospective observational study analyzed 12,818 adult general anesthesia cases performed at University of Michigan Health – Ann Arbor locations between April 1, 2023 and September 30, 2024 on anesthesia machines wit

Frequently Asked Questions

What is the focus of the research published?

The research focuses on GE HealthCare's End-tidal Control software and its effects.

Where was the research conducted?

The research was conducted at the University of Michigan.

How many cases were analyzed in the study?

The study analyzed 12,818 adult general anesthesia cases.

In which journal was the study published?

The study was published in Anesthesia & Analgesia Practice.

ShareAdd on Google
Tags: GEHC GE HealthCare End-tidal Control anesthesia University of Michigan gas flow
Last updated: Oct 16, 2026

Biotech snapshot

Cash runway
$2079M liquidity · $0M/mo burn
Low dilution risk
Lead asset
PET MPIPhase 3
Coronary Artery Disease (CAD) →

Catalyst track record

+32%
best trade around GEHC's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for GEHC.

See every catalyst's timing & PoA →